The hypolipidemic activity of boronated nucleosides in male mice and rats

Metal-Based Drugs

Volumn 3, Issue 4, 1996, Pages 173-183

  Burnham, Bruce S ^a   Sood, Anup ^b   Tomasz, Jeno ^b   Powell, W J ^b   Spielvogel, Bernard F ^b   Chen, S Y ^a   Hall, Iris H ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Boron Biologicals Inc   (United States)

Author keywords

3' aminocyanoborane dideoxythymidine; Boronated nucleoside; Hypolipidemia

Indexed keywords

ANTILIPEMIC AGENT; BORON DERIVATIVE; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL ACYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIPID; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NUCLEOSIDE; PHOSPHATASE; SYNTHETASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030471437     PISSN: 07930291     EISSN: None     Source Type: Journal    
DOI: 10.1155/MBD.1996.173     Document Type: Article

References (24)

1. Hall I.H., Burnham B.S., Rajendran K.G., Chen S.Y., Sood A., Spielvogel B.F., Shaw B.R. (1993) Biomed. Pharmacother. 47, 79.
2. Hall I.H., Burnham B.S., Chang J.J., Sood A., Spielvogel B.F (1994) Metal-Based Drugs 1, 19.
3. Hall I.H., Hall E.S., Chi L.K., Sood A., Spielvogel B.F. (1992) Anticancer Res. 12, 1091.
4. Sood A., Spielvogel B.F., Shaw B.R., Carlton L.D., Burham B.S., Hall E.S., Hall I.H. (1992) Anticancer Res. 12, 335.
5. Sood A., Spielvogel B.F., Shaw B.R., Hall E.S., Chi L.K., Hall I.H. (1992) der Pharm 47, 833.
6. Ness A.T., Pastewka J.V., Peacock A.C. (1959) Clin. Chem. Acta. 10, 229.
7. Bligh E.G., Dyer W.J. (1959) J. Biochem. Physiol. 37, 911.
8. Folch J., Lees M., Stanley G.H.C. (1957) J. Biol. Chem. 226, 497.
9. Bragdon J.H. (1951) Biol. Chem. 190, 513.
10. Stewart C.T., Hendry E.G. (1935) J. Biochem, 29, 1688.
11. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. (1951) J. Biol. Chem. 193, 263.
12. Havel R.L., Eder H.A., Bragdon J.M. (1955) J. Clin. Invest. 34, 1345.
13. Mookerjea E.S., Parks C.E., Kuksis A. (1975) Lipids 10, 374.
14. Goodridge A.G. (1973) J. Biol. Chem. 248, 4318.
15. Hoffman M., Weiss L., and Wieland O.H. (1978) Anal. Biochem. 84, 441.
16. Shefer S., Hauser S., Mosbach E.H. (1978) J. Lipid Res. 9, 328.
17. Haven G.T., Krzemian J.R., Nguyen T.T. (1973) Res. Commun. Chem. Path. Pharmacol. 6, 253.
18. Wada F., Hirata K., Sakameto Y. (1989) J. Biochem. 65, 171.
19. Balasubramaniam S., Mitropoulos K.A., Venkatesam S. (1978) European J. Biochem. 90, 377.
20. Greenspan M.D., Lowenstein J.M. (1968) J. Biol. Chem. 243, 6273.
21. Lamb R.G., Wyrick S.D., Piantadosi C. (1977) Athersclerosis 27, 147.
22. Mavis R.D., Jacob N., Finkelstein J.N., Hall B.P. (1978) J. Lipid Res. 19, 467.
23. Chait A., Iverius P.H., Brunzell J.D. (1982) J. Clin. Invest. 69, 490.
24. Miettinen T.A., Huttunen J.K., Strandberg T., Naukkarinen V., Mattila S., Kumlin T. (1981) Lancet 2, 478.